/

DVA

DaVita Inc.Pre-market

181.78+2.53 +1.41%USD

NYSE · as of Oct 12, 16:00 ET · 20m delayPre-market 183.00 +0.67%

Open

179.61

Prev close

179.25

Day range

179.37182.23

52-week range

101.00247.49

Volume

571.46K0.75×

Mkt cap

11.60B

P/E ttm

15.35

Fwd P/E

10.60

EPS ttm

11.84

Div yield

0.00%

Earnings

Aug 4, 2026

From 52w high

−26.55%

Price Chart

Yahoo Finance · delayed

DVAOct 12, 2026O 179.61H 182.24L 179.37C 181.78+2.53 (+1.41%)Vol 586.40K

SMA 50182.32
SMA 200171.95

1Y change +46.61% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

DVA DaVita Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +1.71%
1 month: +0.13%
3 months: −22.84%
6 months: +19.94%
Year to date: +60.00%
1 year: +46.61%

Valuation & ownership

Market cap: 11.60B
Enterprise value: 26.16B
P/E (ttm): 15.35
Forward P/E: 10.60
PEG ratio: 0.44
Price / book: —
Price / sales (ttm): 0.83
EV / EBITDA: 9.26
EPS (ttm): 11.84
EPS (forward): 17.14
Beta (5y monthly): 0.80
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 63.80M
Float: 33.93M
Short % of float: 15.87%
Short ratio (days): 7.24
Held by insiders: 46.91%
Held by institutions: 48.38%
Avg volume (3m): 759.98K
50-day average: 182.32
200-day average: 171.95
52-week change: +46.61%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 50.9
vs 50-day SMA: −0.30%
vs 200-day SMA: +5.72%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.59%
Realised vol (20d, ann.): 32.0%
From 52-week high: −26.55%
From 52-week low: +79.98%

Signals (TECH)none at the last close

ANR

Analyst Consensus

7 analysts

Consensus

Buy

2.38 on a 1 (strong buy) – 5 (sell) scale

Mean target

219.86

+20.95% implied

Low 165.00Median 220.00High 270.00

Recommendation trend

Now3 / 4 / 1
1m ago3 / 4 /

DES

About DaVita Inc.

Yahoo Finance profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Sector: Healthcare
Industry: Medical Care Facilities
Employees: 78,000
Headquarters: Denver, CO, United States
Website: davita.com
Officers: Mr. Javier J. Rodriguez CEO & Executive Director
Mr. Joel Ackerman CFO & Treasurer
Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer

SEAS

Seasonality · DVA

2007–2026 · monthly returns

Strongest month Nov +5.24%Weakest month Oct −2.36%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-3.8	42.9	-1.7	0.9	25.3	14.5	7.9	-26.7	-0.6	3.9			+60.0%
2025	17.8	-16.1	3.4	-7.5	-3.7	4.5	-1.5	-1.9	-3.5	-10.4	0.6	-5.1	−24.0%
2024	3.2	17.4	8.7	0.7	5.8	-5.8	-1.4	10.5	8.6	-14.7	18.9	-10.0	+42.8%
2023	10.3	-0.2	-1.4	11.4	3.7	7.3	1.5	0.4	-7.7	-18.3	31.4	3.3	+40.3%
2022	-4.7	4.1	0.3	-4.2	-10.0	-18.0	5.3	1.3	-3.0	-11.8	1.0	1.3	−34.4%
2021	-0.0	-13.0	5.5	8.1	3.0	0.3	-0.1	8.7	-11.1	-11.2	-8.5	20.4	−3.1%
2020	6.5	-2.8	-2.0	3.9	2.5	-2.2	10.4	-0.7	-1.3	0.7	27.4	6.9	+56.5%
2019	9.1	1.4	-4.6	1.7	-21.4	29.6	6.4	-5.8	1.2	2.7	22.5	4.5	+45.8%
2018	8.0	-7.7	-8.4	-4.8	6.5	3.9	1.2	-1.4	3.4	-6.0	-1.9	-22.1	−28.8%
2017	-0.7	8.9	-2.1	1.5	-4.0	-2.3	0.0	-9.6	1.4	2.3	0.5	18.3	+12.5%
2016	-3.7	-1.7	11.2	0.7	4.6	0.0	0.3	-16.6	2.2	-11.3	8.1	1.3	−7.9%
2015	-0.9	-0.6	9.0	-0.2	3.3	-5.1	-0.6	-4.3	-4.4	7.2	-5.8	-4.6	−8.0%
2014	2.5	5.9	0.2	0.7	1.9	2.5	-2.6	6.0	-2.1	6.7	-2.0	-1.0	+19.5%
2013	4.4	3.6	-0.9	0.1	4.6	-2.6	-3.6	-7.6	5.9	-1.2	5.9	6.4	+14.7%
2012	7.9	5.8	4.2	-1.8	-8.3	20.9	0.2	-1.2	6.5	8.6	-4.0	2.3	+45.8%
2011	6.3	7.5	7.7	3.0	-4.6	3.0	-3.5	-11.9	-14.8	11.7	8.8	-0.5	+9.1%
2010	1.7	3.1	2.9	-1.5	1.6	-1.6	-8.2	12.7	6.8	3.9	1.3	-4.4	+18.3%
2009	-5.2	-0.2	-6.3	5.5	-2.7	9.6	0.5	4.0	9.5	-6.4	11.7	-0.8	+18.5%
2008	-5.2	-7.1	-3.8	9.7	-1.0	2.4	5.1	2.8	-0.7	-0.5	-11.5	-1.4	−12.0%
2007	-4.0	-0.2	-2.2	2.4	1.1	-2.4	-1.7	8.7	9.8	3.2	-5.0	-9.1	−0.9%

INSD

Insider Activity · DVA

Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

15K shares

Sells, 6 months

1.58M shares

Net shares

−1.56M

Net change in insider shares

−5.00%

Date	Insider	Transaction	Shares	Value
Aug 13, 2026	Schechter Adam HDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Desoer Barbara JDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Yale Phyllis RDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Moore Gregory JDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Pullin Dennis WDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Schoppert Wendy LeeDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Arway Pamela M.Director	Stock Award(Grant) at price 0.00 per share.	278	—
Aug 13, 2026	Hollar Jason MDirector	Stock Award(Grant) at price 0.00 per share.	278	—
Jul 30, 2026	Berkshire Hathaway, Inc.Beneficial Owner of more than 10% of a Class of Security	Sale at price 199.55 per share.	183K	$36.51M
Jun 15, 2026	Rodriguez Javier JChief Executive Officer	Sale at price 209.28 - 209.50 per share.	69.4K	$14.53M
Jun 14, 2026	Waters Kathleen AlyceOfficer	Sale at price 207.84 - 209.17 per share.	15.4K	$3.21M
May 25, 2026	Yale Phyllis RDirector	Stock Gift at price 0.00 per share.	5K	—
May 14, 2026	Desoer Barbara JDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Yale Phyllis RDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Hearty James OOfficer	Sale at price 193.98 per share.	15K	$2.91M
May 14, 2026	Moore Gregory JDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Pullin Dennis WDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Schoppert Wendy LeeDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Schechter Adam HDirector	Stock Award(Grant) at price 0.00 per share.	250	—
May 14, 2026	Arway Pamela M.Director	Stock Award(Grant) at price 0.00 per share.	250	—

CONG

Congress Trades · DVA

House reports since 2025

Members

0 last bought

Buys

~$8.0K

Sells

~$16.0K

Net

−$8.0K

est. bought − sold

Latest

Sep 25, 25

Julie Johnson

Members who traded it

Member	Buys	Sells	Est. net	Last move
Julie Johnson TX32	1	2	−$8.0K	Sold Sep 25, 25

Bought and sold by quarter (est.)

House members' DVA trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Sep 25, 25	Julie Johnson TX32	Joint	Sell	$1,001 - $15,000	Oct 7, 25 (12d)	PDF
Sep 23, 25	Julie Johnson TX32	Joint	Buy	$1,001 - $15,000	Aug 5, 26 (316d)	PDF
Sep 23, 25	Julie Johnson TX32	Joint	Sell	$1,001 - $15,000	Aug 5, 26 (316d)	PDF

From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

DVA

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

DVA

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About DaVita Inc.

Seasonality · DVA

Insider Activity · DVA

Congress Trades · DVA

Members who traded it

Bought and sold by quarter (est.)

Congress Trades · DVA

Members who traded it

Bought and sold by quarter (est.)

Insider Activity · DVA

Seasonality · DVA

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About DaVita Inc.

Financial Snapshot

Earnings & Dividends

News